Correlation Between Annexin Pharmaceuticals and KABE Group

Can any of the company-specific risk be diversified away by investing in both Annexin Pharmaceuticals and KABE Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexin Pharmaceuticals and KABE Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Annexin Pharmaceuticals AB and KABE Group AB, you can compare the effects of market volatilities on Annexin Pharmaceuticals and KABE Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexin Pharmaceuticals with a short position of KABE Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexin Pharmaceuticals and KABE Group.

Diversification Opportunities for Annexin Pharmaceuticals and KABE Group

0.66

Correlation Coefficient

Annexin Pharmaceuticals  KABE Group

Poor diversification

The 3 months correlation between Annexin and KABE is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Annexin Pharmaceuticals AB and KABE Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KABE Group AB and Annexin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexin Pharmaceuticals AB are associated (or correlated) with KABE Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KABE Group AB has no effect on the direction of Annexin Pharmaceuticals i.e., Annexin Pharmaceuticals and KABE Group go up and down completely randomly.

Pair Corralation between Annexin Pharmaceuticals and KABE Group

Assuming the 90 days trading horizon Annexin Pharmaceuticals AB is expected to under-perform the KABE Group. In addition to that, Annexin Pharmaceuticals is 4.06 times more volatile than KABE Group AB. It trades about -0.04 of its total potential returns per unit of risk. KABE Group AB is currently generating about -0.16 per unit of volatility. If you would invest  30,300  in KABE Group AB on December 31, 2024 and sell it today you would lose (3,800) from holding KABE Group AB or give up 12.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Annexin Pharmaceuticals AB  vs.  KABE Group AB

Annexin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

KABE Group AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Annexin Pharmaceuticals and KABE Group

The main advantage of trading using opposite Annexin Pharmaceuticals and KABE Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexin Pharmaceuticals position performs unexpectedly, KABE Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KABE Group will offset losses from the drop in KABE Group's long position.

The idea behind Annexin Pharmaceuticals AB and KABE Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.